RMIT immunologist Dr Kylie Quinn said the availability of alternative vaccines in any given country, including Australia, was a critical factor.
“And when we are faced with the impacts of COVID-19 in our life - health impacts, but also those broader impacts on our ability to open up as a community and avoid lockdowns - then that certainly explains the increased interest in getting these vaccines, too.” AstraZeneca’s efficacy varies slightly depending on what happens to be the dominant variant of the virus in any given setting.
But a British study recently found AstraZeneca prevents hospitalisation in 92 per cent of Delta variant cases, meaning it is still highly effective in preventing serious illness. Earlier this month, the EU's drug regulator said it had recorded 405 cases of TTS after about 45 million doses of the AstraZeneca vaccine.
Ummmmm...you forgot to mention how many of those countries offered an MRNA vaccine post AZ due to concerns about AZ going forward and the need to provide an alternative to encourage uptake...
Better not end up banning AZ. Still my preferred option for when I will feel practically forced to get a shot.